Research Portal

Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

Research output: Contribution to journal › Article › peer-review

Electronic versions

DOI

  • R.C. Coombes
  • L.S. Kilburn
  • C.F. Snowdon
  • R. Paridaens
  • R.E. Coleman
  • S.E. Jones
  • J. Jassem
  • C.J. Van de Velde
  • T. Delozier
  • I. Alvarez
  • L. Del Mastro
  • O. Ortmann
  • K. Diedrich
  • A.S. Coates
  • E. Bajetta
  • S.B. Holmberg
  • D. Dodwell
  • E. Mickiewicz
  • J. Andersen
  • P.E. Lonning
  • G. Coccini
  • J. Forbes
  • M. Castiglione
  • N.S. Stuart
  • A. Stewart
  • L.J. Fallowfield
  • G. Bertelli
  • E. Hall
  • R.G. Bogle
  • M. Carpentieri
  • E. Colajori
  • M. Subar
  • E. Ireland
  • J.M. Bliss

Keywords

  • MEDICINE, GENERAL & INTERNAL
Original languageEnglish
Pages (from-to)559-570
JournalThe Lancet
Volume369
Issue number9561
DOIs
Publication statusPublished - 1 Feb 2007
View graph of relations